Literature DB >> 1069973

Acute myeloblastic leukemia after immunodepressive therapy for primary nonmalignant disease.

G Tchernia, F Mielot, E Subtil, C Parmentier.   

Abstract

Three patients treated with immunodepressive chemotherapy over a period of 43, 60, 38 months respectively, for primary nonmalignant disease, developed AML after cessation of chemotherapy. During the months preceding the AML outbreak, there were hematologic changes with seemed to reveal a preleukemic state. Our 3 patients, and 8 previously published cases, making a total of 11 patients, developed AML after chemical immunodepression for reasons which were neither hematologic nor neoplastic.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1069973     DOI: 10.1007/978-3-642-66312-3_5

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol Blood Cells


  5 in total

1.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

2.  Acute leukaemia after busulphan.

Authors:  H Stott; W Fox; D J Girling; R J Stephens; D A Galton
Journal:  Br Med J       Date:  1977-12-10

Review 3.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

4.  Acute leukemia after cytotoxic treatment for nonmalignant disease in childhood. A case report and review of the literature.

Authors:  W Müller; M Brandis
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

5.  [Acute leukemia after kidney allotransplantation (author's transl)].

Authors:  D Frei; U Binswanger; J Fehr; J Briner; C Sauter; F Largiadèr
Journal:  Blut       Date:  1980-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.